Latest Innovations in Interventional Oncology
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Medical Imaging and Theranostics".
Deadline for manuscript submissions: 30 November 2025 | Viewed by 24
Special Issue Editors
Interests: stents; angioplasty; arterial stiffness; carotid arteries; atherosclerosis; arteries; HCC; TACE
Interests: interventional oncology; interventional radiology; liver cancer; kidney cancer; lung cancer; thermal ablation; chemoembolization; radioembolization; portal vein embolization
Special Issue Information
Dear Colleagues,
This Special Issue highlights cutting-edge diagnostic advancements reshaping interventional oncology, focusing on minimally invasive, image-guided techniques that enhance cancer detection and characterization. Emerging modalities, such as contrast-enhanced ultrasound (CEUS), advanced MRI imaging and CT, and intraprocedural diagnostic modality to guide interventions, have enhanced the performance of tailored oncological treatment. Advanced imaging analytics, including AI-driven lesion segmentation and radiomics, along with AI-driven guidance for the treatment of tumoral lesions, are improving treatment response accuracy. Collectively, these tools empower interventional radiologists to tailor interventions, optimize biopsy strategies, and transform diagnostic paradigms for personalized oncology care.
Dr. Pierleone Lucatelli
Prof. Dr. David C. Madoff
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- contrast-enhanced ultrasound (CEUS)
- hybrid PET-MRI oncology imaging
- optical coherence tomography (OCT) diagnostics
- AI-driven lesion segmentation
- radiomics-based tumor profiling
- liquid biopsy innovations
- endovascular biomarker sampling
- molecular imaging specificity
- real-time tumor characterization
- image-guided diagnostic paradigms
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
